{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:22:53Z","timestamp":1784809373375,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["950852"],"award-info":[{"award-number":["950852"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09246-6","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T11:02:12Z","timestamp":1708772532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic potency of A1 adenosine receptor antagonists in the treatment of cardiovascular diseases, current status and perspectives"],"prefix":"10.1007","volume":"51","author":[{"given":"Amirhossein","family":"Bahreyni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoo","family":"Saeedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulridha Mohammed","family":"Al-Asady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atena","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khazaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Alaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhane","family":"Hanaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Ryzhikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6172-6225","authenticated-orcid":false,"given":"Seyed Mahdi","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,24]]},"reference":[{"key":"9246_CR1","unstructured":"Mendis S, Puska P, Norrving B (2011) Global atlas on cardiovascular disease prevention and control. World Health Organization"},{"key":"9246_CR2","doi-asserted-by":"publisher","first-page":"5982809","DOI":"10.1155\/2017\/5982809","volume":"2017","author":"AM Witkowska","year":"2017","unstructured":"Witkowska AM, Wa\u015bkiewicz A, Zujko ME, Szcze\u015bniewska D, Paj\u0105k A, Stepaniak U et al (2017) Dietary polyphenol intake, but not the Dietary Total antioxidant capacity, is inversely related to Cardiovascular Disease in Postmenopausal Polish women: results of WOBASZ and WOBASZ II studies. Oxidative Med Cell Longev 2017:5982809","journal-title":"Oxidative Med Cell Longev"},{"key":"9246_CR3","doi-asserted-by":"crossref","unstructured":"Pu J, Hastings KG, Boothroyd D, Jose PO, Chung S, Shah JB et al (2017) Geographic variations in Cardiovascular Disease Mortality among Asian American subgroups, 2003\u20132011. J Am Heart Association. ;6(7)","DOI":"10.1161\/JAHA.117.005597"},{"key":"9246_CR4","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41598-017-03434-0","volume":"7","author":"G Istas","year":"2017","unstructured":"Istas G, Declerck K, Pudenz M, Szic KSv, Lendinez-Tortajada V, Leon-Latre M et al (2017) Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease. Sci Rep 7:5120","journal-title":"Sci Rep"},{"issue":"1","key":"9246_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.110.003285","volume":"63","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Linden J, M\u00fcller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update. Pharmacol Rev 63(1):1\u201334","journal-title":"Pharmacol Rev"},{"key":"9246_CR6","doi-asserted-by":"crossref","unstructured":"Yegutkin GG (2008) Nucleotide-and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochimica et Biophysica ACTA (BBA)-Molecular Cell Research. 1783(5):673\u2013694","DOI":"10.1016\/j.bbamcr.2008.01.024"},{"issue":"4","key":"9246_CR7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/ALN.0b013e3181b060f2","volume":"111","author":"HK Eltzschig","year":"2009","unstructured":"Eltzschig HK (2009) Adenosine: an old drug newly discovered. Anesthesiology: The Journal of the American Society of Anesthesiologists 111(4):904\u2013915","journal-title":"Anesthesiology: The Journal of the American Society of Anesthesiologists"},{"key":"9246_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fphar.2017.00243","volume":"8","author":"EA Vecchio","year":"2017","unstructured":"Vecchio EA, White PJ, May LT (2017) Targeting Adenosine receptors for the treatment of Cardiac Fibrosis. Front Pharmacol 8:243","journal-title":"Front Pharmacol"},{"issue":"3","key":"9246_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/molecules22030449","volume":"22","author":"A Ciancetta","year":"2017","unstructured":"Ciancetta A, Jacobson K (2017) Structural probing and molecular modeling of the A3 adenosine receptor: a focus on agonist binding. Molecules 22(3):449","journal-title":"Molecules"},{"key":"9246_CR10","doi-asserted-by":"publisher","first-page":"2740963","DOI":"10.1155\/2017\/2740963","volume":"2017","author":"K Varani","year":"2017","unstructured":"Varani K, Vincenzi F, Ravani A, Pasquini S, Merighi S, Gessi S et al (2017) Adenosine Receptors as a Biological pathway for the anti-inflammatory and beneficial effects of low frequency Low Energy Pulsed Electromagnetic fields. Mediat Inflamm 2017:2740963","journal-title":"Mediat Inflamm"},{"issue":"2","key":"9246_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11302-011-9232-0","volume":"7","author":"D Verzijl","year":"2011","unstructured":"Verzijl D, IJzerman AP (2011) Functional selectivity of adenosine receptor ligands. Purinergic Signalling 7(2):171","journal-title":"Purinergic Signalling"},{"key":"9246_CR12","doi-asserted-by":"crossref","unstructured":"Bahreyni A, Samani SS, Rahmani F, Behnam-Rassouli R, Khazaei M, Ryzhikov M et al (2017) Role of adenosine signaling in the pathogenesis of breast cancer.","DOI":"10.1002\/jcp.25944"},{"key":"9246_CR13","doi-asserted-by":"crossref","unstructured":"Rivkees SA, Wendler CC (2017) Long-term consequences of disrupting adenosine signaling during embryonic development. Mol Aspects Med.","DOI":"10.1016\/j.mam.2017.02.001"},{"issue":"6","key":"9246_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14737140.2017.1316197","volume":"17","author":"TL Whiteside","year":"2017","unstructured":"Whiteside TL (2017) Targeting adenosine in cancer immunotherapy: a review of recent progress. Expert Rev Anticancer Ther 17(6):527\u2013535","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"9246_CR15","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/ijms15022024","volume":"15","author":"S Sheth","year":"2014","unstructured":"Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V (2014) Adenosine receptors: expression, function and regulation. Int J Mol Sci 15(2):2024\u20132052","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9246_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0022-3565(24)37758-4","volume":"287","author":"E Van Schaick","year":"1998","unstructured":"Van Schaick E, Zuideveld K, Tukker H, Langemeijer M, Ijzerman A, Danhof M (1998) Metabolic and cardiovascular effects of the adenosine A1 receptor agonist N6-(p-sulfophenyl) adenosine in diabetic Zucker rats: influence of the disease on the selectivity of action. J Pharmacol Exp Ther 287(1):21\u201330","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"9246_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1124\/jpet.102.046821","volume":"305","author":"H Fraser","year":"2003","unstructured":"Fraser H, Gao Z, Ozeck MJ, Belardinelli L (2003) N-[3\u00aetetrahydrofuranyl]-6-aminopurine riboside, an A1 adenosine receptor agonist, antagonizes catecholamine-induced lipolysis without cardiovascular effects in awake rats. J Pharmacol Exp Ther 305(1):225\u2013231","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"9246_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1124\/jpet.106.114421","volume":"321","author":"AK Dhalla","year":"2007","unstructured":"Dhalla AK, Santikul M, Smith M, Wong M-Y, Shryock JC, Belardinelli L (2007) Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid. J Pharmacol Exp Ther 321(1):327\u2013333","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"9246_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000139364","volume":"51","author":"LA Merkel","year":"1995","unstructured":"Merkel LA, Hawkins ED, Colussi DJ, Greenland BD, Smits GJ, Perrone MH et al (1995) Cardiovascular and antilipolytic effects of the adenosine agonist GR79236. Pharmacology 51(4):224\u2013236","journal-title":"Pharmacology"},{"issue":"3","key":"9246_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00005344-199703000-00017","volume":"29","author":"BF Cox","year":"1997","unstructured":"Cox BF, Clark KL, Perrone MH, Welzel GE, Greenland BD, Colussi DJ et al (1997) Cardiovascular and metabolic effects of adenosine A1-receptor agonists in streptozotocin-treated rats. J Cardiovasc Pharmacol 29(3):417\u2013426","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2\u20133","key":"9246_CR21","first-page":"152","volume":"9","author":"XH Zhao","year":"2000","unstructured":"Zhao XH, Sun XY, Erlinge D, Edvinsson L, Hedner T (2000) Downregulation of adenosine and P2X receptor-mediated cardiovascular responses in heart failure rats. Blood Press 9(2\u20133):152\u2013161","journal-title":"Blood Press"},{"issue":"5","key":"9246_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/sj.bjp.0706043","volume":"144","author":"CW Schindler","year":"2005","unstructured":"Schindler CW, Karcz-Kubicha M, Thorndike EB, M\u00fcller CE, Tella SR, Ferr\u00e9 S et al (2005) Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists. Br J Pharmacol 144(5):642\u2013650","journal-title":"Br J Pharmacol"},{"issue":"1","key":"9246_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00204-003-0513-4","volume":"78","author":"MJ Joosen","year":"2004","unstructured":"Joosen MJ, Bueters TJ, van Helden HP (2004) Cardiovascular effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning. Arch Toxicol 78(1):34\u201339","journal-title":"Arch Toxicol"},{"issue":"1","key":"9246_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1113\/expphysiol.1996.sp003919","volume":"81","author":"T Thomas","year":"1996","unstructured":"Thomas T, Spyer KM (1996) The role of adenosine receptors in the rostral ventrolateral medulla in the cardiovascular response to defence area stimulation in the rat. Exp Physiol 81(1):67\u201377","journal-title":"Exp Physiol"},{"key":"9246_CR25","doi-asserted-by":"crossref","unstructured":"Abdel-Rahman AA, Tao S (1979) Differential alteration of neuronal and cardiovascular responses to adenosine microinjected into the nucleus tractus solitarius of spontaneously hypertensive rats. Hypertension (Dallas, Tex: 1996;27(4):939\u2009\u2013\u200948","DOI":"10.1161\/01.HYP.27.4.939"},{"issue":"2","key":"9246_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/01.HYP.25.2.278","volume":"25","author":"CJ Tseng","year":"1995","unstructured":"Tseng CJ, Ger LP, Lin HC, Tung CS (1995) Attenuated cardiovascular response to adenosine in the brain stem nuclei of spontaneously hypertensive rats. Hypertens (Dallas Tex: 1979) 25(2):278\u2013282","journal-title":"Hypertens (Dallas Tex: 1979)"},{"issue":"3","key":"9246_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0304-3940(96)13205-5","volume":"219","author":"HC Koh","year":"1996","unstructured":"Koh HC, Shin IC, Hwang SJ, Paik DJ (1996) Modification of cardiovascular response of adenosine A 1 receptor agonist by cyclic AMP in the spinal cord of the rats. Neurosci Lett 219(3):195\u2013198","journal-title":"Neurosci Lett"},{"issue":"2","key":"9246_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0304-3940(00)01630-X","volume":"296","author":"BS Kim","year":"2000","unstructured":"Kim BS, Koh HC, Kang JS, Lee H, Shin IC, Om SA et al (2000) Mediation of the cardiovascular response to spinal \u03b3-aminobutyric acid B receptor stimulation by adenosine A 1 receptors in anesthetized rats. Neurosci Lett 296(2):153\u2013157","journal-title":"Neurosci Lett"},{"issue":"1\u20133","key":"9246_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0304-3940(98)00089-5","volume":"243","author":"HC Koh","year":"1998","unstructured":"Koh HC, Shin IC, Hwang SJ, Kang JS, Lee CH, Ha JH et al (1998) Mediation of the cardiovascular response of adenosine A1 receptor through a GABA(B) receptor in the spinal cord of the rat. Neurosci Lett 243(1\u20133):81\u201384","journal-title":"Neurosci Lett"},{"issue":"3","key":"9246_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5152\/balkanmedj.2015.15932","volume":"32","author":"M B\u00fcy\u00fckdelig\u00f6z","year":"2015","unstructured":"B\u00fcy\u00fckdelig\u00f6z M, Hocao\u011flu N, Oransay K, Tun\u00e7ok Y, Kalkan \u015e (2015) The effects of the adenosine receptor antagonists on the reverse of cardiovascular toxic effects induced by Citalopram in-vivo rat model of poisoning. Balkan Med J 32(3):303","journal-title":"Balkan Med J"},{"issue":"4","key":"9246_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4103\/0253-7613.135948","volume":"46","author":"K Oransay","year":"2014","unstructured":"Oransay K, Hocaoglu N, Buyukdeligoz M, Tuncok Y, Kalkan S (2014) The role of adenosine receptors and endogenous adenosine in citalopram-induced cardiovascular toxicity. Indian J Pharmacol 46(4):378\u2013385","journal-title":"Indian J Pharmacol"},{"issue":"7","key":"9246_CR32","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1081\/CLT-200041845","volume":"42","author":"S Kalkan","year":"2004","unstructured":"Kalkan S, Aygoren O, Akgun A, Gidener S, Guven H, Tuncok Y (2004) Do adenosine receptors play a role in Amitriptyline-induced cardiovascular toxicity in rats? J Toxicol Clin Toxicol 42(7):945\u2013954","journal-title":"J Toxicol Clin Toxicol"},{"key":"9246_CR33","unstructured":"Li YL (1996) [Cardiovascular effects and underlying mechanisms of adenosine and its analogues]. Sheng Li Ke xue jin zhan [Progress in physiology]. 27(3):238\u2013240"},{"issue":"1","key":"9246_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/BF00168545","volume":"348","author":"A Conti","year":"1993","unstructured":"Conti A, Monopoli A, Gamba M, Borea PA, Ongini E (1993) Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues. Naunyn Schmiedebergs Arch Pharmacol 348(1):108\u2013112","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"9246_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/cvr\/27.1.129","volume":"27","author":"RC Wesley Jr","year":"1993","unstructured":"Wesley RC Jr., Porzio D, Sadeghi M (1993) Effect of selective A1 adenosine receptor antagonism of postdefibrillation cardiovascular depression: evidence for an antiadrenergic role of endogenous adenosine. Cardiovascular Res 27(1):129\u2013133","journal-title":"Cardiovascular Res"},{"key":"9246_CR36","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2165\/00003495-200161100-00002","volume":"61","author":"SS Gottlieb","year":"2001","unstructured":"Gottlieb SS (2001) Renal effects of adenosine A 1-receptor antagonists in congestive heart failure. Drugs 61:1387\u20131393","journal-title":"Drugs"},{"issue":"11","key":"9246_CR37","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1161\/hc1102.105264","volume":"105","author":"SS Gottlieb","year":"2002","unstructured":"Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S et al (2002) BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105(11):1348\u20131353","journal-title":"Circulation"},{"issue":"8","key":"9246_CR38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cardfail.2007.08.006","volume":"13","author":"HC Dittrich","year":"2007","unstructured":"Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S (2007) The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail 13(8):609\u2013617","journal-title":"J Card Fail"},{"issue":"22","key":"9246_CR39","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1021\/jm00100a020","volume":"35","author":"KA Jacobson","year":"1992","unstructured":"Jacobson KA, Nikodijevic O, Ji XD, Berkich DA, Eveleth D, Dean RL et al (1992) Synthesis and biological activity of N6-(p-sulfophenyl) alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists. J Med Chem 35(22):4143\u20134149","journal-title":"J Med Chem"},{"issue":"1","key":"9246_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/sj.bjp.0702287","volume":"126","author":"S Snowdy","year":"1999","unstructured":"Snowdy S, Liang HX, Blackburn B, Lum R, Nelson M, Wang L et al (1999) A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea\u2010pig. Br J Pharmacol 126(1):137\u2013146","journal-title":"Br J Pharmacol"},{"issue":"4","key":"9246_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1046\/j.1468-2982.2003.00511.x","volume":"23","author":"NJ Giffin","year":"2003","unstructured":"Giffin NJ, Kowacs F, Libri V, Williams P, Goadsby PJ, Kaube H (2003) Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 23(4):287\u2013292","journal-title":"Cephalalgia"},{"key":"9246_CR42","doi-asserted-by":"crossref","unstructured":"Bahreyni A, Samani SS, Ghorbani E, Rahmani F, Khayami R, Toroghian Y et al (2017) Adenosine: an endogenous mediator in the pathogenesis of gynecological cancer.","DOI":"10.1002\/jcp.26056"},{"key":"9246_CR43","doi-asserted-by":"crossref","unstructured":"Bahreyni A, Samani SS, Khazaei M, Ryzhikov M, Avan A, Hassanian SM (2017) Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; current status and perspectives. J Cell Physiol.","DOI":"10.1002\/jcp.26073"},{"issue":"3","key":"9246_CR44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/jcp.25501","volume":"232","author":"S Ebrahimi","year":"2017","unstructured":"Ebrahimi S, Jaberi N, Avan A, Ryzhikov M, Keramati MR, Parizadeh MR et al (2017) Role of thrombin in the pathogenesis of central nervous system inflammatory diseases. J Cell Physiol 232(3):482\u2013485","journal-title":"J Cell Physiol"},{"issue":"12a","key":"9246_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9149(97)00256-7","volume":"79","author":"JC Shryock","year":"1997","unstructured":"Shryock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79(12a):2\u201310","journal-title":"Am J Cardiol"},{"issue":"02","key":"9246_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-0029-1186271","volume":"58","author":"G Veres","year":"2010","unstructured":"Veres G, Radovits T, Otila G, Hirschberg K, Haider H, Krieger N et al (2010) Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass. Thorac Cardiovasc Surg 58(02):86\u201392","journal-title":"Thorac Cardiovasc Surg"},{"issue":"5","key":"9246_CR47","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/00005344-199905000-00005","volume":"33","author":"MJ McVey","year":"1999","unstructured":"McVey MJ, Smits GJ, Cox BF, Kitzen JM, Clark KL, Perrone MH (1999) Cardiovascular pharmacology of the adenosine A1\/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium. J Cardiovasc Pharmacol 33(5):703\u2013710","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"9246_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1113\/jphysiol.2006.108779","volume":"575","author":"MP Walsh","year":"2006","unstructured":"Walsh MP, Marshall JM (2006) The role of adenosine in the early respiratory and cardiovascular changes evoked by chronic hypoxia in the rat. J Physiol 575(1):277\u2013289","journal-title":"J Physiol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09246-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09246-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09246-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:34:13Z","timestamp":1738701253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09246-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,24]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9246"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09246-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,24]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"358"}}